The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
03/23/2009
. If
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
opportunity click
send
me change notification emails
.
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
printed document.
Description of Modification
Modified to add Recovery Act to the Category Explanation field
Document Type:
Modification to Previous
Grants Notice
Funding Opportunity Number:
RFA-MH-09-170
Opportunity Category:
Other
Posted Date:
Mar 23, 2009
Creation Date:
Mar 24, 2009
Original Closing Date for Applications:
May 12, 2009
Current Closing Date for Applications:
May 12, 2009
Archive Date:
Jun 12, 2009
Funding Instrument Type:
Grant
Category of Funding Activity:
Health
Recovery Act
Category Explanation:
Expected Number of Awards:
Estimated Total Program Funding:
$57,000,000
Award Ceiling:
Award Floor:
CFDA Number(s):
93.701
--
Trans-NIH Recovery Act Research Support
Cost Sharing or Matching Requirement:
No
Eligible Applicants
State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility:
Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Agency Name
National Institutes of Health
Description
Purpose. This NIH Funding Opportunity Announcement (FOA), supported by funds provided to the NIH under the American Recovery and Reinvestment Act of 2009 (Recovery Act or ARRA), Public Law 111-5, solicits applications for the following topic areas relevant to research on the heterogeneity of Autism Spectrum Disorders (ASD): Measurement development, Biomarkers/biological signatures, Immune and central nervous systems interactions, Genetics/genomics, Environmental Risk Factors, Model development, Treatment and intervention, and Services research. This FOA provides support for the R01 grant mechanism which supports larger scale studies for which preliminary data exists and proof-of-principle has been established.
Mechanism of Support. This FOA will utilize the NIH Research Project (R01) award mechanism and runs in parallel with the following FOAs of essentially identical scientific scope: 1) RFA-MH-09-171, which solicits applications under the NIH Collaborative Research Grant (R01) award mechanism; 2) RFA-MH-09-172, which solicits applications under the NIH Exploratory/Developmental Research Grant (R21) award mechanism; and 3) RFA-MH-09-173, which solicits applications under the NIH Clinical Exploratory/Developmental Research Grant (R34/Collaborative R34) award mechanism. The R21 mechanism would be used for projects that propose research in the exploratory or preliminary phases. The R34 mechanism would be used for early phases of treatment development.
The following files represent the modifications to this synopsis
with the changes noted within the documents. The list of files is
arranged from newest to oldest with the newest file representing the
current synopsis. Changed sections from the previous document are shown
in a light grey background.
